ArticlePloS one2025
Overexpression of the translocon accessory protein YajC alleviates toxicity of the endogenous pore-forming toxin LdrA in Escherichia coli.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Almost all bacterial species possess toxin-antitoxin (TA) systems. In Escherichia coli, LdrA is a small membrane protein that functions as a pore-forming toxin. Expression of LdrA results in transient growth arrest, from which cells subsequently recover; however, the underlying recovery mechanism remained unknown. In the present study, we investigated the molecular basis for this recovery. Using a genetic screen, we identified YajC, an accessory protein of the SecDF-YajC translocon, as a key factor in counteracting of LdrA toxicity. We demonstrate that overexpression of YajC effectively alleviates LdrA toxicity without affecting its membrane localization or stability. This suppressive activity was specific for the Ldr toxin family, including LdrA and its homolog LdrD. Furthermore, our results indicate that YajC recognition of LdrA requires both its transmembrane and cytoplasmic domains. These findings reveal a novel function for YajC in counteracting a membrane-damaging toxin, distinct from its known role in the Sec-dependent protein translocation pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.